Ginkgo Bioworks DNA Stock
5.7 USD
{{ price }}
-4.362420%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NYSE
Market Cap
330.79M USD
LOW - HIGH [24H]
5.44
-
5.75 USD
VOLUME [24H]
1.45M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-10.54 USD
Ginkgo Bioworks Price Chart
Ginkgo Bioworks DNA Financial and Trading Overview
| Ginkgo Bioworks stock price | 5.7 USD |
| Previous Close | 1.91 USD |
| Open | 1.88 USD |
| Bid | 1.92 USD x 28000 |
| Ask | 1.95 USD x 29200 |
| Day's Range | 1.86 - 1.98 USD |
| 52 Week Range | 1.12 - 4.91 USD |
| Volume | 20.75M USD |
| Avg. Volume | 20.45M USD |
| Market Cap | 4.07B USD |
| Beta (5Y Monthly) | 0.889214 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -10.54 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.24 USD |
DNA Valuation Measures
| Enterprise Value | 3.18B USD |
| Trailing P/E | N/A |
| Forward P/E | -8.863637 |
| PEG Ratio (5 yr expected) | -0.11 |
| Price/Sales (ttm) | 10.42742 |
| Price/Book (mrq) | 2.5161293 |
| Enterprise Value/Revenue | 8.157 |
| Enterprise Value/EBITDA | -1.88 |
Trading Information
Ginkgo Bioworks Stock Price History
| Beta (5Y Monthly) | 0.889214 |
| 52-Week Change | -17.72% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 4.91 USD |
| 52 Week Low | 1.12 USD |
| 50-Day Moving Average | 1.43 USD |
| 200-Day Moving Average | 1.92 USD |
DNA Share Statistics
| Avg. Volume (3 month) | 20.45M USD |
| Avg. Daily Volume (10-Days) | 26.81M USD |
| Shares Outstanding | 1.59B |
| Float | 1.16B |
| Short Ratio | 8.13 |
| % Held by Insiders | 9.20% |
| % Held by Institutions | 73.73% |
| Shares Short | 183.29M |
| Short % of Float | 14.18% |
| Short % of Shares Outstanding | 8.79% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -447.90% |
| Gross Margin | 63.80% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -48.79% |
| Return on Equity (ttm) | -106.69% |
Income Statement
| Revenue (ttm) | 390M USD |
| Revenue Per Share (ttm) | 0.22 USD |
| Quarterly Revenue Growth (yoy) | -52.10% |
| Gross Profit (ttm) | 273.49M USD |
| EBITDA | -1692385024 USD |
| Net Income Avi to Common (ttm) | -1719393024 USD |
| Diluted EPS (ttm) | -0.97 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.21B USD |
| Total Cash Per Share (mrq) | 0.58 USD |
| Total Debt (mrq) | 404.1M USD |
| Total Debt/Equity (mrq) | 25.14 USD |
| Current Ratio (mrq) | 6.924 |
| Book Value Per Share (mrq) | 0.775 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -322884992 USD |
| Levered Free Cash Flow (ttm) | 379.66M USD |
Profile of Ginkgo Bioworks
| Country | United States |
| State | MA |
| City | Boston |
| Address | 27 Drydock Avenue |
| ZIP | 02210 |
| Phone | 877 422 5362 |
| Website | https://www.ginkgobioworks.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 1292 |
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Q&A For Ginkgo Bioworks Stock
What is a current DNA stock price?
Ginkgo Bioworks DNA stock price today per share is 5.7 USD.
How to purchase Ginkgo Bioworks stock?
You can buy DNA shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Ginkgo Bioworks?
The stock symbol or ticker of Ginkgo Bioworks is DNA.
Which industry does the Ginkgo Bioworks company belong to?
The Ginkgo Bioworks industry is Biotechnology.
How many shares does Ginkgo Bioworks have in circulation?
The max supply of Ginkgo Bioworks shares is 58.03M.
What is Ginkgo Bioworks Price to Earnings Ratio (PE Ratio)?
Ginkgo Bioworks PE Ratio is now.
What was Ginkgo Bioworks earnings per share over the trailing 12 months (TTM)?
Ginkgo Bioworks EPS is -10.54 USD over the trailing 12 months.
Which sector does the Ginkgo Bioworks company belong to?
The Ginkgo Bioworks sector is Healthcare.
Ginkgo Bioworks DNA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| Nasdaq US 700 Small Cap Index NQUS700SC | 2030.58 USD — |
-6.66
|
— — | 2030.36 USD — | 2092.28 USD — | — - | — — |
| Nasdaq CRB Monitor Global Canna HERBALAUNR | 134.01 AUD 88.7 USD |
+1.1
|
— — | 133.84 AUD 88.58 USD | 134.45 AUD 88.99 USD | — - | — — |
| NYSE COMPOSITE (DJ) NYA | 18767.19 USD — |
-3.92
|
— — | — — | — — | — - | — — |
| Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG | 2654.77 USD — |
-6.16
|
— — | 2649.3 USD — | 2734.22 USD — | — - | — — |
| Nasdaq CRB Monitor Global Canna HERBAL | 107.94 USD — |
+0.23
|
— — | 107.93 USD — | 108.09 USD — | — - | — — |
- {{ link.label }} {{link}}